Diabetes Research
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.
Participants must have a diagnosis of type 2 diabetes
Participants must have confirmed cardiovascular disease
Participants must have HbA1c 7.0% to 10.5%
Participants must have a body mass index (BMI) 25 kilograms per meter squared (kg/m²)
Participants must not have had a major cardiovascular event within the last 60 days
Participants must not have type 1 diabetes mellitus
Participants must not have a history of severe hypoglycemia and/or hypoglycemia unawareness within the last 6 months
Participants must not have a history of proliferative diabetic retinopathy; or diabetic maculopathy; or non-proliferative diabetic retinopathy that requires acute treatment
Participants must not be currently planning a coronary, carotid, or peripheral artery revascularization
Participants must not have a history of pancreatitis
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.